Commercializing The Success Of Scottish Life Sciences Will Rely On Scale-Up Space And Government DirectionSteve Jarvis2024-11-28T14:19:20+00:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
Pioneer Group Adds NunaBio To Venture Building ProgrammeSteve Jarvis2024-11-28T14:45:20+00:00April 21st, 2023|Investment, News|
Life Science Accelerator Programme: How Cutting-Edge Companies Are Growing Organically At BioCity NottinghamAmy Cotterill2024-11-28T14:46:11+00:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
NanoSyrinx Joins Life Sciences Incubator In NottinghamAmy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investment Showcase: Connecting Entrepreneurs With Expert Growth FacilitatorsAmy Cotterill2024-11-28T14:47:59+00:00March 23rd, 2023|Accelerator, Investment, News|
Five Questions With Harry Pickering, Portfolio Director & Head Of UK InvestmentSteve Jarvis2024-11-28T14:48:26+00:00February 21st, 2023|Article, Headline Article, Investment|
Pioneer Group Tenant MIP Discovery Secure Funding From Bill & Melinda Gates FoundationSteve Jarvis2023-04-03T14:24:52+01:00February 16th, 2023|Colworth Park, News|
OMass Therapeutics Raises $100 million To Progress Drug Pipeline In Immunology And Rare DiseasesGemma Cann2024-11-28T14:55:20+00:00April 28th, 2022|BioCity Nottingham, News|
Invizius Awarded Second Biomedical Catalyst GrantGemma Cann2022-06-30T11:30:18+01:00April 26th, 2022|BioCity Glasgow, News|
